These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 24923966

  • 1. Clinical and metabolic evaluation of patients with history of renal calculi in Qazvin, Iran.
    Charkhchian M, Samani S, Merat E.
    Ir J Med Sci; 2015 Dec; 184(4):731-5. PubMed ID: 24923966
    [Abstract] [Full Text] [Related]

  • 2. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ, Bozorgmehri S, Kuo J, Canales M, Bird VG, Canales B.
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [Abstract] [Full Text] [Related]

  • 3. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO, Schmiedl A, Wipplinger J.
    Eur J Med Res; 2009 Sep 01; 14(9):378-92. PubMed ID: 19748857
    [Abstract] [Full Text] [Related]

  • 4. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
    Eisner BH, Eisenberg ML, Stoller ML.
    Urology; 2010 Jun 01; 75(6):1289-93. PubMed ID: 20018350
    [Abstract] [Full Text] [Related]

  • 5. Body size and 24-hour urine composition.
    Taylor EN, Curhan GC.
    Am J Kidney Dis; 2006 Dec 01; 48(6):905-15. PubMed ID: 17162145
    [Abstract] [Full Text] [Related]

  • 6. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M, Capuano M, Cangiano G, Carnovale V, Ferrara P, Petrarulo M, Marangella M.
    Nephrol Dial Transplant; 2006 Jul 01; 21(7):1870-5. PubMed ID: 16595587
    [Abstract] [Full Text] [Related]

  • 7. Idiopathic calcium nephrolithiasis. 2. Differences between hypercalciuric and normocalciuric persons with recurrent kidney stone formation and persons without such a history.
    Wilson DR, Pylypchuk G, Ehrig U.
    Can Med Assoc J; 1979 Mar 17; 120(6):666-9. PubMed ID: 436048
    [Abstract] [Full Text] [Related]

  • 8. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F, CLU Working Group.
    Arch Ital Urol Androl; 2015 Jul 07; 87(2):105-20. PubMed ID: 26150027
    [Abstract] [Full Text] [Related]

  • 9. Effect of diclofenac-Na on 24-hour urinary excretion of creatinine, calcium, uric acid and glycosaminoglycans in adult patients with recurrent calcium oxalate nephrolithiasis.
    Hemal AK, Sidhu H, Thind SK, Nath R, Vaidyanathan S.
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan 07; 27(1):44-6. PubMed ID: 2744906
    [Abstract] [Full Text] [Related]

  • 10. Biochemical and dietary factors of uric acid stone formation.
    Trinchieri A, Montanari E.
    Urolithiasis; 2018 Apr 07; 46(2):167-172. PubMed ID: 28246885
    [Abstract] [Full Text] [Related]

  • 11. Body fat content and distribution and urinary risk factors for nephrolithiasis.
    Pigna F, Sakhaee K, Adams-Huet B, Maalouf NM.
    Clin J Am Soc Nephrol; 2014 Jan 07; 9(1):159-65. PubMed ID: 24202136
    [Abstract] [Full Text] [Related]

  • 12. Successful Diabetic Control as Measured by Hemoglobin A1c Is Associated with Lower Urine Risk Factors for Uric Acid Calculi.
    Maciolek KA, Penniston KL, Jhagroo RA, Best SL.
    J Endourol; 2018 Aug 07; 32(8):771-776. PubMed ID: 29896970
    [Abstract] [Full Text] [Related]

  • 13. [Sodium excretion in children with lithogenic disorders].
    Kovacević L, Kovacević S, Smoljanić Z, Peco-Antić A, Kostić N, Gajić M, Kovacević N, Jovanović O.
    Srp Arh Celok Lek; 1998 Aug 07; 126(9-10):321-6. PubMed ID: 9863402
    [Abstract] [Full Text] [Related]

  • 14. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A, Meola M, D'Alessandro C, Bernabini G, Pasquali E, Carpi A, Barsotti G.
    Biomed Pharmacother; 2007 Jan 07; 61(1):86-90. PubMed ID: 17184967
    [Abstract] [Full Text] [Related]

  • 15. Effect of Ramadan fasting on urinary risk factors for calculus formation.
    Miladipour AH, Shakhssalim N, Parvin M, Azadvari M.
    Iran J Kidney Dis; 2012 Jan 07; 6(1):33-8. PubMed ID: 22218117
    [Abstract] [Full Text] [Related]

  • 16. Can 24-hour urine stone risk profiles predict urinary stone composition?
    Torricelli FC, De S, Liu X, Calle J, Gebreselassie S, Monga M.
    J Endourol; 2014 Jun 07; 28(6):735-8. PubMed ID: 24460026
    [Abstract] [Full Text] [Related]

  • 17. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
    Negri AL, Spivacow R, Del Valle E, Pinduli I, Marino A, Fradinger E, Zanchetta JR.
    Urol Res; 2007 Oct 07; 35(5):247-51. PubMed ID: 17786420
    [Abstract] [Full Text] [Related]

  • 18. Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis.
    Millman S, Strauss AL, Parks JH, Coe FL.
    Kidney Int; 1982 Oct 07; 22(4):366-70. PubMed ID: 7176335
    [Abstract] [Full Text] [Related]

  • 19. Idiopathic calcium nephrolithiasis. 1. Differences in urine crystalloids, urine saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone formation.
    Pylypchuk G, Ehrig U, Wilson DR.
    Can Med Assoc J; 1979 Mar 17; 120(6):658-65. PubMed ID: 436047
    [Abstract] [Full Text] [Related]

  • 20. Nephrolithiasis in Cushing's disease: prevalence, etiopathogenesis, and modification after disease cure.
    Faggiano A, Pivonello R, Melis D, Filippella M, Di Somma C, Petretta M, Lombardi G, Colao A.
    J Clin Endocrinol Metab; 2003 May 17; 88(5):2076-80. PubMed ID: 12727957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.